Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pulse Biosciences (PLSE) Return on Capital Employed (2022 - 2025)

Historic Return on Capital Employed for Pulse Biosciences (PLSE) over the last 4 years, with Q3 2025 value amounting to 0.75%.

  • Pulse Biosciences' Return on Capital Employed rose 600.0% to 0.75% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.75%, marking a year-over-year increase of 600.0%. This contributed to the annual value of 0.66% for FY2024, which is 500.0% up from last year.
  • Latest data reveals that Pulse Biosciences reported Return on Capital Employed of 0.75% as of Q3 2025, which was up 600.0% from 0.61% recorded in Q2 2025.
  • In the past 5 years, Pulse Biosciences' Return on Capital Employed ranged from a high of 0.51% in Q1 2025 and a low of 1.88% during Q2 2022
  • In the last 4 years, Pulse Biosciences' Return on Capital Employed had a median value of 0.75% in 2025 and averaged 0.85%.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first skyrocketed by 11800bps in 2023, then crashed by -4900bps in 2024.
  • Quarter analysis of 4 years shows Pulse Biosciences' Return on Capital Employed stood at 0.76% in 2022, then decreased by -3bps to 0.78% in 2023, then grew by 30bps to 0.55% in 2024, then plummeted by -38bps to 0.75% in 2025.
  • Its Return on Capital Employed stands at 0.75% for Q3 2025, versus 0.61% for Q2 2025 and 0.51% for Q1 2025.